NRx Pharmaceuticals (NRXP) announced that the U.S. Food and Drug Administration, FDA, has received the Company’s Abbreviated New Drug Application, ANDA, for KETAFREE, a preservative-free intravenous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback